{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T14:09:24Z","timestamp":1764684564763,"version":"3.46.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008519","name":"University of Arkansas for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008519","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006229","name":"Oak Ridge Institute for Science and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006229","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.mrfmmm.2004.09.018","type":"journal-article","created":{"date-parts":[[2005,8,17]],"date-time":"2005-08-17T07:05:28Z","timestamp":1124262328000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Lymphocyte Hprt mutant frequency and sperm toxicity in C57BL\/6 mice treated chronically with Azathioprine"],"prefix":"10.1016","volume":"578","author":[{"given":"Sachin V.","family":"Bendre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph G.","family":"Shaddock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph E.","family":"Patton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasily N.","family":"Dobrovolsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Albertini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H.","family":"Heflich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrfmmm.2004.09.018_bib1","first-page":"898","article-title":"Biochemistry and pharmacology of purine analogues","author":"Elion","year":"1967","journal-title":"Fed. Proc."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib2","series-title":"Antineoplastic and Immunosuppressive Agents Part II","first-page":"404","article-title":"Azathioprine","author":"Elion","year":"1975"},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib3","unstructured":"USPDI Drug information for the health care professional, USP DI (USP Dispensing Information), Engelwood CO: Micromedex Thomson Healthcare, 2001."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/978-1-4615-5381-6_96","article-title":"Azathioprine treatment and thiopurine metabolism in rheumatic diseases. Introduction and first results of investigation","volume":"431","author":"Stolk","year":"1998","journal-title":"Adv. Exp. Med. Biol."},{"issue":"57\u201368","key":"10.1016\/j.mrfmmm.2004.09.018_bib5","first-page":"52","article-title":"Management of inflammatory bowel disease","volume":"57","author":"Botoman","year":"1998","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib6","unstructured":"B.A. Chabner, C.J. Allegra, G.A. Curt, P. Calabresi, Antineoplastic agents, in: J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A.G. Gilman (Eds.), Goodman and Gilman's the Pharmacological Basis of Therapeutics, 9th ed., McGraw-Hill, New York, 1990, pp. 1233\u20131287."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib7","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/00004836-198712000-00009","article-title":"Immunosuppressant therapy of inflammatory bowel disease. Pharmacologic and clinical aspects","volume":"9","author":"Goldstein","year":"1987","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/03602538508991433","article-title":"The pharmacology and metabolism of the thiopurine drugs 6-mercaptopurine and Azathioprine","volume":"16","author":"Van Scoik","year":"1985","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib9","series-title":"Antineoplastic and Immunosuppressive Agents, Part II","first-page":"384","article-title":"6-Thiopurines","author":"Paterson","year":"1975"},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib10","first-page":"596","article-title":"Detection of females heterozygous for the Lesch-Nyhan mutation by 8-azaguanine-resistant growth of cultured fibroblasts","volume":"77","author":"Felix","year":"1971","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib11","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0022-3565(24)36860-0","article-title":"Tissue specific toxicities of the anticancer drug 6-thioguanine is dependent on the Hprt status in transgenic mice","volume":"282","author":"Aubrecht","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.ge.19.120185.001015","article-title":"HPRT: gene structure, expression, and mutation","volume":"19","author":"Stout","year":"1985","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1383-5742(97)00024-0","article-title":"Development and utilization of the rat lymphocyte hprt mutation assay","volume":"387","author":"Aidoo","year":"1997","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1289\/ehp.9399135","article-title":"In vivo mutations in human blood cells: biomarkers for molecular epidemiology","volume":"99","author":"Albertini","year":"1993","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0027-5107(94)90320-4","article-title":"International Commission for Protection Against Environmental Mutagens and Carcinogens. Working paper no. 3. Somatic mutant frequency, mutation rates and mutational spectra in the human population in vivo","volume":"304","author":"Cole","year":"1994","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0092-8674(79)90182-X","article-title":"The HPRT locus","volume":"16","author":"Caskey","year":"1979","journal-title":"Cell"},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0165-1161(85)90022-6","article-title":"A method to quantify spontaneous and in vivo induced thioguanine-resistant mouse lymphocytes","volume":"147","author":"Jones","year":"1985","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/em.2850180304","article-title":"Enumeration of 6-thioguanine-resistant T-lymphocytes in the peripheral blood of nonhuman primates (cynomolgus monkeys)","volume":"18","author":"Zimmer","year":"1991","journal-title":"Environ. Mol. Mutagen"},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib19","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3181\/00379727-107-26758","article-title":"Detection of agents which interfere with the immune response","author":"Nathan","year":"1961","journal-title":"Proc. Soc. Exp. Biol."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib20","unstructured":"IARC Azathioprine. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Some Antineoplastic and Immunosuppressive Agents, vol. 26, International Agency for Research on Cancer, Lyon, 1981, pp. 47\u201378."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF01952557","article-title":"Effect of the rat liver S9 fraction on the mutagenicity of Azathioprine in the Salmonella\/mammalian microsome assay","volume":"40","author":"Nepomnaschy","year":"1984","journal-title":"Experientia"},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/(SICI)1098-2280(1999)34:2\/3<131::AID-EM12>3.0.CO;2-K","article-title":"Analysis of gene mutations and clastogenicity following short-term treatment with Azathioprine in MutaMouse","volume":"34","author":"Smith","year":"1999","journal-title":"Environ. Mol. Mutagen"},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib23","first-page":"26","article-title":"Comet assay and micronucleus test after 4-week oral treatment of mice with melphalan or Azathioprine","author":"Cinelli","year":"2001","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0028-2243(71)90053-0","article-title":"Pregnancy following kidney transplantation","author":"Givers","year":"1971","journal-title":"Eur. J. Obstet. Gynec."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib25","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.0954-6820.1967.tb10869.x","article-title":"Chromosome studies in patients treated with Azathioprine and amethopterin","volume":"182","author":"Jensen","year":"1967","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib26","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archinte.1971.00310210117014","article-title":"Chromosome aberrations in the child of a kidney transplant recipient","volume":"128","author":"Leb","year":"1971","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0027-5107(76)90082-8","article-title":"Cytogenetic analysis of human chromosomes and its value for the estimation of genetic risk","volume":"41","author":"Kucerova","year":"1976","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0027-5107(79)90140-4","article-title":"Enumeration of 6-thioguanine-resistant peripheral blood lymphocytes in man as a potential test for somatic cell mutations arising in vivo","volume":"61","author":"Strauss","year":"1979","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0165-1218(79)90143-5","article-title":"Investigation into the mutagenic activity of Azathioprine (Imuran) in different test systems","author":"van Went","year":"1979","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib30","unstructured":"IARC Azathioprine (Group 1). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Suppl. 7, International Agency for Research on Cancer, Lyon, 1987, p. 119."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib31","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1136\/bmj.2.6203.1461","article-title":"Collaborative United Kingdom\u2013Australasian study of cancer in patients treated with immunosuppressive drugs","volume":"2","author":"Kinlen","year":"1979","journal-title":"Br. Med. J."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0002-9343(85)90245-1","article-title":"Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment","volume":"78","author":"Kinlen","year":"1985","journal-title":"Am. J. Med."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00007890-198402000-00010","article-title":"Premalignant and malignant skin lesions in renal transplant patients","volume":"37","author":"Blohme","year":"1984","journal-title":"Transplantation"},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib34","first-page":"10","article-title":"Selection for HPRT mutant T-lymphocytes in humans receiving purine analogue medications","author":"Ardell","year":"2000","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib35","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1126\/science.288.5465.514","article-title":"Emergence of genetic instability in children treated for leukemia","volume":"288","author":"Finette","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib36","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1046\/j.1365-3083.2000.00742.x","article-title":"Azathioprine associated T-cell mutations in insulin-dependent diabetes mellitus","volume":"51","author":"Falta","year":"2000","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib37","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/01.CIR.92.4.862","article-title":"Frequency of hypoxanthine guanine phosphoribosyltransferase (HPRT-) T cells in the peripheral blood of cardiac transplant recipients. A noninvasive technique for the diagnosis of allograft rejection","volume":"92","author":"Ansari","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0165-1161(94)90053-1","article-title":"An analysis of in vivo hprt mutant frequency in circulating T-lymphocytes in the normal human population: a comparison of four datasets","volume":"313","author":"Robinson","year":"1994","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib39","first-page":"261","article-title":"Purine nucleotide pyrophosphorylases in 6-mercaptopurine-sensitive and -resistant human leukemias","author":"Davidson","year":"1964","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-3476(68)80413-5","article-title":"Effects of Azathioprine in a disorder of uric acid metabolism and cerebral function","author":"Nyhan","year":"1968","journal-title":"J. Pediat."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1005348504512","article-title":"The recognition of Lesch-Nyhan syndrome as an inborn error of purine metabolism","volume":"20","author":"Nyhan","year":"1997","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib42","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0002-9343(64)90104-4","article-title":"A familial disorder of uric acid metabolism and central nervous system function","author":"Lesch","year":"1964","journal-title":"Am. J. Med."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib43","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1126\/science.155.3770.1682","article-title":"Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis","volume":"155","author":"Seegmiller","year":"1967","journal-title":"Science"},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib44","series-title":"The Metabolic Basis of Inherited Disease","first-page":"1007","article-title":"Hypoxanthine phosphoribosyltransferase deficiency: the Lesch-Nyhan syndrome and gouty arthritis","author":"Stout","year":"1989"},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib45","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/(SICI)1098-2280(1998)32:3<236::AID-EM6>3.0.CO;2-Y","article-title":"Culture and propagation of Hprt mutant T-lymphocytes isolated from mouse spleen","volume":"32","author":"Meng","year":"1998","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/1098-2280(2000)36:4<283::AID-EM4>3.0.CO;2-8","article-title":"7,12-Dimethylbenz[a]anthracene-induced mutation in the Tk gene of Tk(\u00b1) mice: automated scoring of lymphocyte clones using a fluorescent viability indicator","volume":"36","author":"Dobrovolsky","year":"2000","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/em.20002","article-title":"Characterization of Hprt Mutations in cDNA and genomic DNA of T-cell mutants from control and 1,3-butadiene-exposed male B6C3F1 mice and F344 rats","volume":"43","author":"Meng","year":"2004","journal-title":"Envrion. Mol. Mutagen."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib48","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1073\/pnas.72.11.4425","article-title":"Chemical induction of sperm abnormalities in mice","volume":"72","author":"Wyrobek","year":"1975","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib49","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1016\/0006-2952(85)90430-7","article-title":"Thiopurine methyltransferase: mouse kidney and liver assay conditions, biochemical properties and strain variation","volume":"34","author":"Otterness","year":"1985","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/clin.1995.1020","article-title":"Characterization of in vivo mutated T cell clones from patients with systemic lupus erythematosus","volume":"74","author":"Theocharis","year":"1995","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib51","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/ana.410360508","article-title":"Myelin basic protein peptide specificity and T-cell receptor gene usage of HPRT mutant T-cell clones in patients with multiple sclerosis","volume":"36","author":"Lodge","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib52","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1006\/clim.1998.4664","article-title":"Selection of hprt mutant T cells as surrogates for dividing cells reveals a restricted T cell receptor BV repertoire in insulin-dependent diabetes mellitus","volume":"90","author":"Falta","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0027-5107(75)90318-8","article-title":"The mutagenicity of Azathioprine in mice, Drosophila melanogaster and Neurospora crassa","volume":"28","author":"Clark","year":"1975","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/em.2850260103","article-title":"Relative sensitivity of the endogenous hprt gene and lacI transgene in ENU-treated Big Blue B6C3F1 mice","volume":"26","author":"Skopek","year":"1995","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib55","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/carcin\/20.2.269","article-title":"Hprt mutant frequency and molecular analysis of Hprt mutations in Fischer 344 rats treated with thiotepa","volume":"20","author":"Chen","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib56","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1242\/dev.118.3.859","article-title":"Age-dependent selection against hypoxanthine phosphoribosyl transferase-deficient cells in mouse haematopoiesis","volume":"118","author":"Samuel","year":"1993","journal-title":"Development"},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib57","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1126\/science.160.3826.425","article-title":"X-linked hypoxanthine-guanine phosphoribosyl transferase deficiency: heterozygote has two clonal populations","volume":"160","author":"Migeon","year":"1968","journal-title":"Science"},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00684949","article-title":"Plasma concentrations and organ distribution of thiopurines after oral application of Azathioprine in mice","volume":"28","author":"Kurowski","year":"1991","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.mrfmmm.2004.09.018_bib59","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0041-008X(72)90192-5","article-title":"Detection of chemical mutagens by the dominant lethal assay in the mouse","volume":"23","author":"Epstein","year":"1972","journal-title":"Toxicol. Appl. Pharmacol."}],"container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510705003738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510705003738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T14:07:02Z","timestamp":1764684422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027510705003738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":59,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0027510705003738"],"URL":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2004.09.018","relation":{},"ISSN":["1386-1964"],"issn-type":[{"type":"print","value":"1386-1964"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphocyte Hprt mutant frequency and sperm toxicity in C57BL\/6 mice treated chronically with Azathioprine","name":"articletitle","label":"Article Title"},{"value":"Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2004.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}